Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Wnt signalling in kidney diseases: dual roles in renal injury and repair
2012
The RAGE Axis
2010
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
2004
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
2013
Diabetic retinopathy
2010 Standout
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Cellular and molecular mechanisms of fibrosis
2007 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Protein carbonylation, cellular dysfunction, and disease progression
2006
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Mouse Models of Diabetic Nephropathy
2004
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
2018
Evaluation of rage isoforms, ligands, and signaling in the brain
2005
Angiotensin receptors: a new role in cancer?
2005
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
2011
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
2006
Direct antiatherosclerotic effects of PPAR agonists
2008
Angiotensin and diabetic retinopathy
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The role of EMT in renal fibrosis
2011
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
2015
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria
2011
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Platelet-derived growth factor receptor signaling activates pericyte–myofibroblast transition in obstructive and post-ischemic kidney fibrosis
2011
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
2012
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
2009
AT2 receptors: Functional relevance in cardiovascular disease
2008
Cardiovascular complications in diabetes mellitus
2005
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
2008
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
2009
Pathophysiological regulation of the AT1-receptor and implications for vascular disease
2006
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis
2007
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
2009
Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord–Stromal Tumors of the Testis
2015
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 Standout
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
2011
Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice
2012
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
PPAR dual agonists: Are they opening Pandora's Box?
2007
Sterile inflammation: sensing and reacting to damage
2010 Standout
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
2016
Targeted Inhibition of β-Catenin/CBP Signaling Ameliorates Renal Interstitial Fibrosis
2011
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways
2009
Lipoxins: update and impact of endogenous pro-resolution lipid mediators
2007
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
2001
Hibiscus sabdariffa Polyphenolic Extract Inhibits Hyperglycemia, Hyperlipidemia, and Glycation-Oxidative Stress while Improving Insulin Resistance
2011
Knocking down barriers: advances in siRNA delivery
2009 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Frequent Mutation and Nuclear Localization of β-Catenin in Sertoli Cell Tumors of the Testis
2013
Mouse Models of Diabetic Nephropathy
2009 Nobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation
2007
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
2008
Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis
2006
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Advanced Glycation End Products
2006 Standout
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
2013
Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
2012
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling
2015
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
2010
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
B-Type Natriuretic Peptide Prevents Acute Hypertrophic Responses in the Diabetic Rat Heart
2003
Diabetic Cardiomyopathy
2018 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
2004
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to Melanoma
2007 StandoutNobel
Epigenetics
2010
Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail
2009
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Renal Connective Tissue Growth Factor Induction in Experimental Diabetes Is Prevented by Aminoguanidine
2002
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Hibiscus sabdariffa Inhibits Vascular Smooth Muscle Cell Proliferation and Migration Induced by High Glucose—A Mechanism Involves Connective Tissue Growth Factor Signals
2009
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation
2007
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Recent insights into diabetic renal injury from thedb/dbmouse model of type 2 diabetic nephropathy
2010
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
2006
Advanced Glycation End Products and Diabetic Complications
2014
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
2009
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
2014
Mechanisms of Renal Fibrosis
2017 Standout
Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
2010
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E–Deficient Mice
2002
Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
2015
Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes
2005
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
2011
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
2010
Works of Markus Lassila being referenced
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
2007
Densin is a novel cell membrane protein of sertoli cells in the testis
2006
-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys
2010
Comparison of enalapril and valsartan in cyclosporine A‐induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high‐sodium diet
2000
CYCLOSPORINE INDUCES MYOCARDIAL CONNECTIVE TISSUE GROWTH FACTOR IN SPONTANEOUSLY HYPERTENSIVE RATS ON HIGH-SODIUM DIET1
2001
Advanced Glycation End Products in Diabetes‐Associated Atherosclerosis and Renal Disease: Interventional Studies
2005
Accelerated Nephropathy in Diabetic Apolipoprotein E-Knockout Mouse
2004
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice
2005
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse
2007
Imatinib Attenuates Diabetic Nephropathy in Apolipoprotein E-Knockout Mice
2005
Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
2002
Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes
2002
Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors
2004
Imatinib Attenuates Diabetes-Associated Atherosclerosis
2004
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
2004
Rosiglitazone Attenuates Atherosclerosis in a Model of Insulin Insufficiency Independent of Its Metabolic Effects
2005
Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
2001
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
2004